Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
| Name | Organization |
|---|---|
| Danielle Bancroft (Chair) | Best Practice Software |
| Melva Peters | Jenaker Consulting |
| John Hatem (Scribe) | Independent Consultant |
| Margaret Weiker | NCPDP |
| Christof Gessner | HL7 Germany |
| Peter Sergent | HL7 New Zealand |
| Stephen Chu | Australian Digital Health Agency (ADHA) |
| Scott Robertson | Kaiser Permanente |
| Corey Spears | Mitre |
| Jean Duteau | Duteau Design |
| Shelly Spiro | Pharmacy HIT Collaborative |
| Dave Hill | MITRE |
| Frank McKinney | POCP |
Agenda Items and Notes
Meeting Notes from previous meeting
- 2021-10-25 Agenda/Meeting Notes - accepted by acclimation
- 2021-11-01 Agenda/Meeting Notes - accepted by acclimation
Project Review
Project Proposals
- Project Proposals in Review
- no Project Proposals to review this week
Project Scope Statements
Discussion of MedicationKnowledge changes (Jean Duteau)
- - no updates today
Catalog Updates (John Hatem)
- - no pharmacy specific issues discussed but these topics were on the agenda
- plan is to release next Catalog IG update in May. Need to follow-up and confirm if this is expected to include Pharmacy catalog
- they have removed the CatalogEntry resource
- they have made 3 suggested changes to ClinicalUseDefinition resource, all of which were accepted.
- they also have been working on Device Definition issues - unrelated to Pharmacy
- Next meeting will be November 19, 2021
Workflow Update (John Hatem)
- - no meeting this week
Healthcare Product Update (John Hatem)
- - reported that Pharmacy will use the Device to parent Device relationship, where Device will be used to represent the Port/lumen e.g. distal; and parent Device will be used to represent the triple lumen catheter. I have three outstanding questions back to O&O:
- What element in Device should we use to specify the port/lumen?
- What element in Device should we use to specify the triple lumen catheter?
- If we needed to specify the gauge of the lumen/port, which element in Device would we use? and which resource should we do this in? the Device where the port/lumen is specified, or in the parent Device?
NCPDP Updates (NCPDP Members)
- No updates. NCPDP WG Meetings were held last week. Most Task Group Meetings will resume the week of November 15th.
Global Supply Chain Project (Scott)
Medication List Guidance project (John)
- - no updates this past week
Projects
Pharmacy Templates
PDex Formulary (Corey)
- Discussed three issues today-see trackers for details
- https://jira.hl7.org/browse/FHIR-31349 : motion made by Corey. seconded by JeanD. Motion passed 12-0-0
https://jira.hl7.org/browse/FHIR-34085 : motion made by Corey, seconded by Scott R. Motion passed 12-0-0
https://jira.hl7.org/browse/FHIR-33183 : motion made by Corey, seconded by Jean D. Motion passed 12-0-0- new search parameters link: HL7.FHIR.US.DAVINCI-DRUG-FORMULARY\Search Parameters - FHIR v4.0.1
- https://jira.hl7.org/browse/FHIR-31349 : motion made by Corey. seconded by JeanD. Motion passed 12-0-0
FHIR (Group)
BR&R managed resources review
New Resource - FormularyItem
Preparation for Normative
Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)
- 34195 : motion by Melva,seconded by Scott R. Motion passed 11-0-0
- 34218:
Any Other Business
Next meeting
- November 15, 2021